Neogenomics (NEO) Latest Stock Analysis Report β Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $17.25, +2.19% vs the prior close of $16.88.
- Volume 1.31M shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NEO rises 2.2% to $17.25, 3 up days in a row. Closed at $17.25, +2.19% vs the prior close of $16.88. Day range $16.61β$17.34, opened at $17.00.
NEO daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 β NEO rises 2.2% to $17.25, 3 up days in a row
- Closed at $17.25, +2.19% vs the prior close of $16.88. Day range $16.61β$17.34, opened at $17.00.
- Volume was 1.31M shares, 0.6x its 50-day average of 2.02M.
- Price is -1.6% vs its 50-day average ($17.53) and +37.6% vs its 200-day average ($12.54).
- 52-week range $7.07β$20.15; today's close sits at 78% of that range, 14.4% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 β NEO rises 1.3% to $16.88
- Closed at $16.88, +1.32% vs the prior close of $16.66. Day range $16.45β$17.25, opened at $16.49.
- Volume was 1.62M shares, 0.8x its 50-day average of 2.05M.
- Price is -3.5% vs its 50-day average ($17.50) and +34.9% vs its 200-day average ($12.51).
- 52-week range $7.07β$20.15; today's close sits at 75% of that range, 16.2% below the 52-week high.
Oct 13, 2026 β NEO rises 2.8% to $16.66
- Closed at $16.66, +2.84% vs the prior close of $16.20. Day range $15.98β$16.98, opened at $16.30.
- Volume was 2.23M shares, 1.1x its 50-day average of 2.06M.
- Price is -4.7% vs its 50-day average ($17.49) and +33.4% vs its 200-day average ($12.49).
- 52-week range $7.07β$20.15; today's close sits at 73% of that range, 17.3% below the 52-week high.
Oct 12, 2026 β NEO dips 0.9% to $16.20
- Closed at $16.20, -0.92% vs the prior close of $16.35. Day range $15.86β$16.35, opened at $16.35.
- Volume was 1.18M shares, 0.6x its 50-day average of 2.09M β lighter than usual.
- Price is -7.3% vs its 50-day average ($17.47) and +29.9% vs its 200-day average ($12.47).
- 52-week range $7.07β$20.15; today's close sits at 70% of that range, 19.6% below the 52-week high.
Oct 9, 2026 β NEO rises 2.1% to $16.35
- Closed at $16.35, +2.06% vs the prior close of $16.02. Day range $16.00β$16.66, opened at $16.02.
- Volume was 1.39M shares, 0.6x its 50-day average of 2.17M.
- Price is -6.3% vs its 50-day average ($17.45) and +31.3% vs its 200-day average ($12.45).
- 52-week range $7.07β$20.15; today's close sits at 71% of that range, 18.9% below the 52-week high.
Oct 8, 2026 β NEO rises 0.3% to $16.02
- Closed at $16.02, +0.31% vs the prior close of $15.97. Day range $15.41β$16.09, opened at $15.72.
- Volume was 3.52M shares, 1.5x its 50-day average of 2.27M.
- Price is -8.2% vs its 50-day average ($17.44) and +28.9% vs its 200-day average ($12.43).
- 52-week range $7.07β$20.15; today's close sits at 68% of that range, 20.5% below the 52-week high.
Oct 7, 2026 β NEO slides 3.3% to $15.97, a 1-month low
- Closed at $15.97, -3.27% vs the prior close of $16.51. Day range $15.88β$16.64, opened at $16.36.
- Volume was 3.19M shares, 1.4x its 50-day average of 2.26M.
- Price is -8.4% vs its 50-day average ($17.43) and +28.7% vs its 200-day average ($12.41).
- 52-week range $7.07β$20.15; today's close sits at 68% of that range, 20.7% below the 52-week high.
Oct 6, 2026 β NEO slides 13.7% to $16.51, a 1-month low on 2.3x normal volume
- Closed at $16.51, -13.70% vs the prior close of $19.13. Day range $16.47β$20.15, opened at $20.00.
- Volume was 5.10M shares, 2.3x its 50-day average of 2.19M β unusually heavy trading.
- Price is -5.0% vs its 50-day average ($17.38) and +33.3% vs its 200-day average ($12.39).
- 52-week range $7.07β$20.15; today's close sits at 72% of that range, 18.1% below the 52-week high.
Oct 5, 2026 β NEO jumps 3.6% to $19.13
- Closed at $19.13, +3.57% vs the prior close of $18.47. Day range $18.28β$19.13, opened at $18.48.
- Volume was 2.05M shares, 0.9x its 50-day average of 2.19M.
- Price is +10.5% vs its 50-day average ($17.31) and +54.7% vs its 200-day average ($12.36).
- 52-week range $7.07β$20.05; today's close sits at 93% of that range, 4.6% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 2, 2026 β NEO jumps 3.9% to $18.47
- Closed at $18.47, +3.88% vs the prior close of $17.78. Day range $17.94β$18.69, opened at $17.99.
- Volume was 2.30M shares, 1.1x its 50-day average of 2.18M.
- Price is +7.4% vs its 50-day average ($17.20) and +49.9% vs its 200-day average ($12.32).
- 52-week range $7.07β$20.05; today's close sits at 88% of that range, 7.9% below the 52-week high.
NEO latest news & SEC filings
Every SEC filing by or about NEO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Stone Warren converted options/RSUs into 17,562 shares on Oct 1, 2026; now holds 198,640
- Stone Warren had withheld for taxes 6,911 shares on Oct 1, 2026; now holds 191,729
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
- Item 5.03 β Amended its charter or bylaws / changed fiscal year.
This is a results-day filing: the earnings press release is attached as an exhibit.
Sep 3, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 25, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 25, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 14, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Aug 6, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Aunan Greg D sold 20,000 shares at $16.07 (β$321.40K) on Aug 4, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 4, 2026 Β· Form 144 β Planned insider sale
Notice of proposed sale (Form 144) β an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 30, 2026 Β· Form 144 β Planned insider sale
Notice of proposed sale (Form 144) β an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 30, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $2.24M (prior year -$45.09M) (swung to profit vs Jun 30, 2025)
Jul 28, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 22, 2026 Β· Form 8-K/A β Current report (amended)
Amended current report
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 β Reported other events the company considers important.
Things to know before you trade NEO
- Last results release: Oct 5, 2026 (8-K Item 2.02). Previous ones: Jul 28, 2026, Apr 28, 2026, Feb 17, 2026. Based on that rhythm, the next report is likely around Jan 4, 2027 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.91% (largest 13.7%).
- Liquidity: about 2.53M shares (β$43.59M) trade per day on average.
- 52-week position: $17.25 vs a range of $7.07β$20.15 (78% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 6 sales; latest: Greg D Aunan sold 20,000 shares on Aug 4, 2026.
- Latest filings: 8-K Oct 5, 2026; 8-K Aug 11, 2026; 10-Q Jul 28, 2026.
- Share count: 128.48M shares outstanding (Jul 24, 2026), -0.5% vs a year earlier.
- Listing: Nasdaq Β· industry: Services-Testing Laboratories.
NEO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 17.00 | 17.34 | 16.61 | 17.25 | 1.31M |
| Oct 14, 2026 | 16.49 | 17.25 | 16.45 | 16.88 | 1.62M |
| Oct 13, 2026 | 16.30 | 16.98 | 15.98 | 16.66 | 2.23M |
| Oct 12, 2026 | 16.35 | 16.35 | 15.86 | 16.20 | 1.18M |
| Oct 9, 2026 | 16.02 | 16.66 | 16.00 | 16.35 | 1.39M |
| Oct 8, 2026 | 15.72 | 16.09 | 15.41 | 16.02 | 3.52M |
| Oct 7, 2026 | 16.36 | 16.64 | 15.88 | 15.97 | 3.19M |
| Oct 6, 2026 | 20.00 | 20.15 | 16.47 | 16.51 | 5.10M |
| Oct 5, 2026 | 18.48 | 19.13 | 18.28 | 19.13 | 2.05M |
| Oct 2, 2026 | 17.99 | 18.69 | 17.94 | 18.47 | 2.30M |
| Oct 1, 2026 | 18.18 | 18.76 | 17.74 | 17.78 | 2.47M |
| Sep 30, 2026 | 18.76 | 18.97 | 18.28 | 18.36 | 2.47M |
| Sep 29, 2026 | 19.30 | 19.75 | 18.58 | 18.74 | 2.70M |
| Sep 28, 2026 | 19.02 | 19.59 | 19.01 | 19.29 | 1.30M |
| Sep 25, 2026 | 19.56 | 19.75 | 18.87 | 19.33 | 2.02M |
| Sep 24, 2026 | 18.47 | 19.73 | 18.40 | 19.56 | 2.95M |
| Sep 23, 2026 | 18.69 | 19.08 | 18.27 | 18.36 | 2.91M |
| Sep 22, 2026 | 19.28 | 19.60 | 18.83 | 18.89 | 4.00M |
| Sep 21, 2026 | 19.92 | 20.05 | 19.28 | 19.41 | 1.44M |
| Sep 18, 2026 | 19.91 | 20.03 | 19.40 | 19.91 | 4.40M |
About Neogenomics
Neogenomics (NEO) is listed on the Nasdaq and classified by the SEC under βServices-Testing Laboratoriesβ. Its business address is in FORT MYERS, FL. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1077183.
NEO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Marjorie C Green | Director | Jun 3, 2026 |
| Neil Gunn | Director | Jun 3, 2026 |
| Stephen M Kanovsky | Director | Jun 3, 2026 |
| Michael Aaron Kelly | Director | Jun 3, 2026 |
| John P. Kenny | Director | Jun 3, 2026 |
| David Brian Perez | Director | Jun 3, 2026 |
| Carolyn S Starrett | Director | Jun 25, 2026 |
| Lynn A. Tetrault | Director | Jun 17, 2026 |
| Felicia Williams | Director | Jun 3, 2026 |
| Anthony P. Zook | Chief Executive Officer | Apr 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Greg D Aunan | Chief Accounting Officer | Aug 6, 2026 |
| Abhishek Jain | Chief Financial Officer | Mar 2, 2026 |
| Alicia C Olivo | EVP, GC & Business Development | Sep 3, 2026 |
| Jeffrey Scott Sherman | Chief Financial Officer | Feb 24, 2026 |
| Warren Stone | Pres & Chief Operating Officer | Aug 25, 2026 |
| Anthony P. Zook | Chief Executive Officer | Apr 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 4, 2026 | Greg D Aunan | Sale | 20,000 | $16.07 |
| Jun 15, 2026 | Lynn A. Tetrault | Sale | 5,307 | $11.10 |
| Jun 9, 2026 | Lynn A. Tetrault | Sale | 5,307 | $11.29 |
| Jan 20, 2026 | Warren Stone | Sale | 22,128 | $12.50 |
| Nov 25, 2025 | Alicia C Olivo | Sale | 20,916 | $12.00 |
| Oct 16, 2025 | Alicia C Olivo | Sale | 4,918 | $10.00 |
NEO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | β | $-108.03M | β | $5.23M |
| Dec 31, 2024 | β | $-78.73M | β | $7.02M |
| Dec 31, 2023 | β | $-87.97M | β | $-1.95M |
| Dec 31, 2022 | β | $-144.25M | β | $-65.99M |
| Dec 31, 2021 | β | $-8.35M | β | $-26.72M |
Latest balance sheet: total assets $1.35B, total liabilities $566.51M, cash $145.54M (as of Jun 30, 2026).
NEO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 5, 2026 | 8-K Item 2.02 (results) | $19.13 |
| Jul 28, 2026 | 8-K Item 2.02 (results) | $13.40 |
| Apr 28, 2026 | 8-K Item 2.02 (results) | $9.02 |
| Feb 17, 2026 | 8-K Item 2.02 (results) | $11.44 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $12.49 |
| Oct 28, 2025 | 8-K Item 2.02 (results) | $9.92 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $5.25 |
| Apr 29, 2025 | 8-K Item 2.02 (results) | $6.58 |
| Feb 18, 2025 | 8-K Item 2.02 (results) | $12.41 |
| Nov 5, 2024 | 8-K Item 2.02 (results) | $14.93 |
| Jul 29, 2024 | 8-K Item 2.02 (results) | β |
| Apr 30, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Services-Testing Laboratories
UL Solutions (ULS)20/20 Biolabs (AIDX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on NEO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.